Table 1.

Baseline clinical and pathologic characteristics of all 55 patients with SBP who had cytogenetics by FISH available

CharacteristicHigh risk (n = 22; 40%)
n (%)
Standard risk (n = 33; 60%), n (%)P value
Median age, y (range) 62 (28-78) 62 (29-83) .72 
Male 16 (73) 22 (67) 1.00 
White 17 (77) 31 (91) .127 
Serum monoclonal protein detectable  21/21 (100) 32/32 (100) 1.00 
M spike (g/dL), median (range) 0.75 (0.4-1.9) 1 (0.4-1.8) .436 
Abnormal FLC ratio  14 (64) 18 (55) .373 
Maximal SBP diameter of 5 cm or greater 8/11 (73) 8/24 (33) .035 
Minimal marrow involvement present  20 (91) 21 (64) .029 
High-risk cytogenetic subtype§     
Del (17p) 11 (50) —  
Gain (1q) 13 (59) —  
t(4;14) 2 (9) —  
t(14;16) 1 (5) —  
t(14;20) —  
CharacteristicHigh risk (n = 22; 40%)
n (%)
Standard risk (n = 33; 60%), n (%)P value
Median age, y (range) 62 (28-78) 62 (29-83) .72 
Male 16 (73) 22 (67) 1.00 
White 17 (77) 31 (91) .127 
Serum monoclonal protein detectable  21/21 (100) 32/32 (100) 1.00 
M spike (g/dL), median (range) 0.75 (0.4-1.9) 1 (0.4-1.8) .436 
Abnormal FLC ratio  14 (64) 18 (55) .373 
Maximal SBP diameter of 5 cm or greater 8/11 (73) 8/24 (33) .035 
Minimal marrow involvement present  20 (91) 21 (64) .029 
High-risk cytogenetic subtype§     
Del (17p) 11 (50) —  
Gain (1q) 13 (59) —  
t(4;14) 2 (9) —  
t(14;16) 1 (5) —  
t(14;20) —  

The boldface P values are statistically significant at P < .05.

Detectable by either immunofixation or mass-fixation

Abnormal ratio defined as <0.26 or >1.65

Clonal plasma cells were considered positive if monoclonal plasma cells were detected by flow cytometry or immunohistochemistry on the bone marrow biopsy core or aspirate.

§

Some patients have multiple different high-risk cytogenetic subtypes and are counted in each category.

or Create an Account

Close Modal
Close Modal